BE
BEACTICA THERAPEUTICS AB
Grant-FundedCORDISDeveloping a new treatment and companion diagnostic to improve outcomes for glioblastoma patients
Biotech
BEACTICA THERAPEUTICS AB is a private SME recorded in CORDIS in Sweden, with participation in 11 EU research and innovation projects. Its recorded projects include “Developing a new treatment and companion diagnostic to improve outcomes for glioblastoma patients”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€4,433,264
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇸🇪Sweden
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
BEACTICA THERAPEUTICS AB is a private SME recorded in CORDIS in Sweden, with participation in 11 EU research and innovation projects. Its recorded projects include “Developing a new treatment and companion diagnostic to improve outcomes for glioblastoma patients”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
Biotech
Tags:Biotech
Company Info
BEACTICA THERAPEUTICS AB Info
Funding
EU Grants€4,433,264